Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: '7 hydroxy pipat maleate'

Search results for: '7 hydroxy pipat maleate'

Items 31-40 of 79

Page
per page
  1. Otamixaban
    A3690 Otamixaban
    Target: Factor Xa
    Summary: Direct factor Xa inhibitors,potent and selective
      ≥22.35 mg/mL
  2. PF-04217903 methanesulfonate
    A3712 PF-04217903 methanesulfonate
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      Soluble in DMSO
  3. Saquinavir mesylate
    A3791 Saquinavir mesylate
    Summary: HIV Protease Inhibitor
  4. Alvelestat
    B1037 Alvelestat
    Target: NE
    Summary: NE inhibitor
      ≥27.3 mg/mL
  5. Valdecoxib
    B1459 Valdecoxib
    Target: COX
    Summary: COX-2 inhibitor
      insoluble in H2O; ≥15.72 mg/mL
  6. FT-207 (NSC 148958)
    B1474 FT-207 (NSC 148958)
    Summary: DNA/RNA synthesis inhibitor
      ≥100 mg/mL
  7. Mizoribine
    B1472 Mizoribine
    Target: Synthases/Synthetases
    Summary: DNA/RNA synthesis inhibitor
      insoluble in EtOH; ≥88.2 mg/mL
  8. Pizotifen Malate
    B2007 Pizotifen Malate
    Target: 5-HT2 Receptors|D2 Receptors
    Summary: 5-HT receptor antagonist
      ≥21.48 mg/mL
  9. Cefoselis Sulfate
    B1906 Cefoselis Sulfate
    Target: Peptidoglycan synthesis
    Summary: beta-lactam antibiotic
      ≥62.1 mg/mL
  10. Azaguanine-8
    B1667 Azaguanine-8
    Summary: Purine analogs
      insoluble in H2O; insoluble in EtOH; ≥3.93 mg/mL

Items 31-40 of 79

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 71item
  2. Natural Products 1 item
  3. Kits 1 item
  4. Lab Reagents 1 item
Reversibility
  1. Reversible 4item
  2. Irreversible 2item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 4item
  3. Proteasome 3item
  4. Histone Deacetylases (HDACs) 4item
  5. PI3K 3item
  6. Raf 3item
  7. CSF-1R 1 item
  8. FLT3 2item
  9. GSK-3 2item
  10. Factor Xa 1 item
  11. VEGFR 4item
  12. PDGFR 4item
  13. c-Kit 2item
  14. RET 1 item
  15. p38 2item
  16. FGFR 1 item
  17. Deubiquitinating enzymes (DUBs) 1 item
  18. PP1 1 item
  19. PP2A 1 item
  20. MET 1 item
  21. Trk Receptors 1 item
  22. STAT 1 item
  23. Topoisomerases 1 item
  24. Cytochrome P450 (CYP450) 1 item
  25. HMG-CoA Reductases 2item
  26. c-MET 3item
  27. 5-HT2 Receptors 1 item
  28. DGAT 1 item
  29. Insulin and Insulin-like Receptors 1 item
  30. PARP 1 item
  31. ALK 1 item
  32. Myosin light chain kinases (MLCKs) 1 item
  33. D2 Receptors 1 item
  34. 5-HT1 Receptors 1 item
  35. Angiotensin-Converting Enzymes (ACEs) 1 item
  36. Autophagy 1 item
  37. COX 1 item
  38. GpIIb/IIIa receptor 1 item
  39. Peroxynitrite 1 item
  40. Ron 1 item
  41. Synthases/Synthetases 1 item
  42. Histamine H1 Receptors 1 item
  43. Phospholipases 1 item
  44. Noradrenaline reuptake 1 item
  45. cAMP 1 item
  46. Sulfonylurea receptors 1 item
  47. Peptidoglycan synthesis 1 item
  48. Nuclear Receptors 1 item
  49. Catechol O-Methyltransferase (COMT) 1 item
  50. Angiotensin AT1 Receptors 1 item
  51. DREADD Ligands 1 item
  52. PP4 1 item
  53. Ub-conjugating enzyme (E2) complex 1 item
  54. P97 ATPase 1 item
  55. ITK 1 item
  56. NUAK 1 item
  57. NOP Receptors 1 item
  58. PRMT 1 item
  59. Serotonin (5-HT) reuptake 1 item
  60. NE 1 item
  61. PIKfyve 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 1 item
  3. Bladder Cancer 1 item
  4. B-lymphoid Malignancies 1 item
  5. Brain Injuries Studies 1 item
  6. Breast Cancer 7item
  7. Cancer 34item
  8. Chronic Lymphocytic Leukemia 2item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 3item
  11. Colorectal Cancer 7item
  12. Depression 1 item
  13. Diabetes 2item
  14. Glioblastoma 4item
  15. Glioma 1 item
  16. Hepatocellular Carcinoma 1 item
  17. Inflammatory Diseases 2item
  18. Lung Cancer 1 item
  19. Lung Carcinoma 1 item
  20. Lymphoma 5item
  21. Mantle Cell Lymphoma 2item
  22. Melanoma 2item
  23. Multiple Myeloma 4item
  24. Myeloma 1 item
  25. Neuroblastoma 2item
  26. Neurocognitive Disorders 1 item
  27. Non-small Cell Lung Cancer 3item
  28. Obsessive-Compulsive Disorder 1 item
  29. Ovarian Cancer 3item
  30. Pancreatic Cancer 2item
  31. Prostate Cancer 1 item
  32. Renal Cancer 1 item
  33. Rheumatoid Arthritis 1 item
  34. Schizophrenia 2item
  35. Thyroid Cancer 1 item
  36. Type 2 Diabetes 2item